0000000000410441

AUTHOR

Manuel Delgado

showing 16 related works from this author

Stable Green Electroluminescence from an Iridium Tris-Heteroleptic Ionic Complex

2012

An ionic tris-heteroleptic iridium complex gives green light-emitting electrochemical cells (LECs) with unprecedented performances for this part of the visible spectrum. The devices are very bright (>1000 cd m–2), efficient (∼3%), and stable (>55 h). The novel complex is prepared using a new and efficient synthetic procedure. We show that there is a mixed orbital formation originating from the two different orthometalating ligands resulting in photophysical properties that lie between those of its two bis-heteroleptic analogs. Therefore, tris-heteroleptic complexes provide new avenues for fine-tunning the emission properties and to bridge gaps between a series of bis-heteroleptic complexes.

TrisMaterials scienceGeneral Chemical EngineeringIonic bondingchemistry.chemical_elementGeneral ChemistryElectroluminescencePhotochemistryElectrochemical cellchemistry.chemical_compoundchemistryMaterials ChemistryLight-emitting electrochemical cellIridiumIonic complexVisible spectrumChemistry of Materials
researchProduct

Lucrecia Borgia : drama en cinco actos

1841

Teatre castellà S. XIX Fonts
researchProduct

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

2021

[Background & Aims] The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening or procedures has been interrupted or delayed because of the COVID-19 pandemic.

Hepatocellular carcinomaLCmedicine.medical_treatment:diagnóstico::toma de decisiones clínicas [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]NursesRC799-869Liver transplantationCholangiocarcinomaClinical trialsENS-CCAInterquartile rangeDecisió Presa dePandemic:Other subheadings::/diagnosis [Other subheadings]:virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES]CERO-19Pandèmia de COVID-19 2020-Immunology and AllergyiCCA intrahepatic cholangiocarcinomaCOVID-19 coronavirus disease 2019Liver Cancer Outcome in the COVID-19-pandemic ProjectSettore MED/12 - Gastroenterologiaddc:617IQRGastroenterologyBCLC Barcelona Clinic Liver Cancer:Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES]:neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias hepáticas [ENFERMEDADES]Diseases of the digestive system. GastroenterologyManagementClinical PracticeClinical trialEuropean Network for the Study of Cholangiocarcinoma:Diagnosis::Clinical Decision-Making [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Fetge - Malalties - DiagnòsticInterquartile rangeLiver cancerLiver cancerPROGRESSION-FREE SURVIVALLiver Cancermedicine.medical_specialtyCoronavirus disease 2019 (COVID-19):Otros calificadores::/diagnóstico [Otros calificadores]610 Medicine & health:Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Liver Neoplasms [DISEASES]LT liver transplantationArticleBarcelona Clinic Liver CancerInternal MedicinemedicineENS-CCA European Network for the Study of CholangiocarcinomaHepatologybusiness.industryCERO-19 Liver Cancer Outcome in the COVID-19-pandemic ProjectCOVID-19IQR Interquartile rangemedicine.diseaseBCLCClinical trialEmergency medicineObservational study610 Medizin und GesundheitbusinessHCC hepatocellular carcinomaLC liver cancerSARS-CoV-2 severe acute respiratory syndrome coronavirus-2
researchProduct

A deep-blue emitting charged bis-cyclometallated iridium(iii) complex for light-emitting electrochemical cells

2013

We report here a new cationic bis-cyclometallated iridium(III) complex, 1, with deep-blue emission at 440 nm and its use in Light-emitting Electrochemical Cells (LECs). The design is based on the 2′,6′-difluoro-2,3′-bipyridine skeleton as the cyclometallating ligand and a bis-imidazolium carbene-type ancillary ligand. Furthermore, bulky tert-butyl substituents are used to limit the intermolecular interactions. LECs have been driven both at constant voltage (6 V) and constant current (2.5 mA cm−2). The performances are significantly improved with the latter method, resulting overall in one of the best reported greenish-blue LECs having fast response (17 s), light intensity over 100 cd m−2 an…

Materials scienceLigandIntermolecular forceCationic polymerizationAnalytical chemistrychemistry.chemical_elementGeneral ChemistryPhotochemistryElectrochemical cellLight intensitychemistryMaterials ChemistryConstant currentIridiumDeep blueJ. Mater. Chem. C
researchProduct

Tuning the photophysical properties of cationic iridium(iii) complexes containing cyclometallated 1-(2,4-difluorophenyl)-1H-pyrazole through function…

2012

Four new heteroleptic iridium(III) complexes in the family [Ir(dfppz)(2)((NN)-N-boolean AND)](+), where Hdfppz = 1-(2,4-difluorophenyl)-1H-pyrazole and (NN)-N-boolean AND = 6-phenyl-2,2'-bipyridine (1), 4,4'-(di-tert-butyl)-6-phenyl-2,2'-bipyridine (2), 4,4'-(di-tert-butyl)-6,6'-diphenyl-2,2'-bipyridine (3) and 4,4'-bis(dimethylamino)-2,2'-bipyridine (4), have been synthesized as the hexafluoridophosphate salts and fully characterized. Single crystal structures of ligand 3 and the precursor [Ir-2(dfppz)(4)(mu-Cl)(2)] have been determined, along with the structures of the complexes 4{[Ir(dfppz)(2)(1)][PF6]}center dot 3CH(2)Cl(2), [Ir(dfppz)(2)(3)][PF6]center dot CH2Cl2 and [Ir(dfppz)(2)(4)][…

Absorption spectroscopyChemistryLigandAnalytical chemistrychemistry.chemical_element02 engineering and technologyNuclear magnetic resonance spectroscopyPyrazole010402 general chemistry021001 nanoscience & nanotechnology01 natural sciences22'-Bipyridine0104 chemical sciencesInorganic Chemistrychemistry.chemical_compoundCrystallographyIridiumTriplet state0210 nano-technologyAcetonitrileDalton Trans.
researchProduct

International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis

2020

Background & Aims: Information on safety and efficacy of systemic treatment in patients with hepatocellular carcinoma (HCC) under dialysis are limited due to patient exclusion from clinical trials. Thus, we aimed to evaluate the rate, prevalence, tolerability, and outcome of sorafenib in this population. Methods: We report a multicenter study comprising patients from Latin America and Europe. Patients treated with sorafenib were enrolled; demographics, dose modifications, adverse events (AEs), treatment duration, and outcome of patients undergoing dialysis were recorded. Results: As of March 2018, 6156 HCC patients were treated in 44 centres and 22 patients were concomitantly under dial…

NiacinamidesafetySorafenibdialysimedicine.medical_specialtyCarcinoma HepatocellularHepatocellular carcinomamedicine.medical_treatmentPopulationadverse eventAntineoplastic Agentssurvival03 medical and health sciences0302 clinical medicineRenal DialysisInterquartile rangeInternal medicineHepatocellular carcinoma; adverse events; dialysis; safety; sorafenib; survivalmedicineHumanseducationDialysisAgededucation.field_of_studyHepatologybusiness.industryPhenylurea CompoundsLiver NeoplasmsRetrospective cohort studyHepatitis CSorafenibmedicine.diseaseadverse eventsEuropeTreatment OutcomeTolerability030220 oncology & carcinogenesisHepatocellular carcinomadialysissorafenib030211 gastroenterology & hepatologybusinessmedicine.drugLiver International
researchProduct

Convergence of Theory and Experiment on the Role of Preorganization, Quantum Tunneling, and Enzyme Motions into Flavoenzyme-Catalyzed Hydride Transfer

2017

Hydride transfer is one of the most common reactions catalyzed by enzymatic systems, and it has become an object of study because of possible significant quantum tunneling effects. In the present work, we provide a combination of theoretical QM/MM simulations and experimental measurements of the rate constants and kinetic isotopic effects (KIEs) for the hydride transfer reaction catalyzed by morphinone reductase, MR. Quantum mechanical tunneling coefficients, computed in the framework of variational transition-state theory, play a significant role in this reaction, reaching values of 23.8 ± 5.5 for the lightest isotopologue—one of the largest values reported for enzymatic systems. This pred…

Morphinone reductase010304 chemical physicsHydrideChemistryThermodynamicsGeneral Chemistry010402 general chemistry01 natural sciencesQM/MMCatalysismolecular dynamicsArticle0104 chemical sciencesReaction coordinateQM/MMMolecular dynamicsReaction rate constantComputational chemistrykinetic isotope effectshydride transfer0103 physical sciencesmorphinone reductaseQuantumQuantum tunnelling
researchProduct

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (C…

2019

Background and aims Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of OBV/PTV/r +/- DSV (3D/2D regimen) with or without ribavirin (RBV) in HCV or HCV/HIV co-infected patients with GT1/GT4 and CKD (IIIb-V stages), including those under hemodialysis and peritoneal dialysis in routine clinical practice in Spain in 2015. Material and methods Non-interventional, retrospective, multicenter data collection study in 31 Spanish sites. Socio-demographic, clinical variables, study treatment characteristics, effectiveness and toler…

Malemedicine.medical_treatmentHIV InfectionsHepacivirus0302 clinical medicine:Infections::Virus Diseases::Hepatitis Viral Human::Hepatitis C::Hepatitis C Chronic [DISEASES]ribavirina2-Naphthylaminemediana edad:virosis::infecciones por virus ARN::infecciones por Retroviridae::infecciones por Lentivirus::infecciones por VIH [ENFERMEDADES]ancianoSulfonamidesCoinfectionfarmacoterapiaLiver Diseasesvirus diseasesValineInfeccions per VIH - TractamentCirrhosisNephrology/drug therapyMedicine030211 gastroenterology & hepatologyDrug Therapy Combinationinsuficiencia renalmedicine.medical_specialty:virosis::hepatitis viral humana::hepatitis C::hepatitis C crónica [ENFERMEDADES]GenotypeProlineSciencecompuestos macrocíclicosSurgical and Invasive Medical ProceduresGastroenterology and HepatologyAntiviral AgentsMicrobiologyUrinary System ProceduresPeritoneal dialysis03 medical and health sciencesDrug TherapyHumansLost to follow-upRenal Insufficiency ChronicUracilAgedRetrospective StudiesFlavivirusesanilidasOrganismsOrgan Transplantationmedicine.diseasedigestive system diseasesRegimenchemistryHIV-1Malalties del ronyóCarbamatesgenotipoCyclopropanesRNA virusesantivíricosSustained Virologic ResponsePhysiologyhumanoschemistry.chemical_compoundChronic Kidney DiseaseMedicine and Health SciencesRenal TransplantationAnilidesRenal Insufficiency030212 general & internal medicinePathology and laboratory medicinecoinfecciónMultidisciplinaryKidney diseasesHepatitis C virus:Infections::Infections::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::Infections::Virus Diseases::HIV Infections [DISEASES]resultado del tratamientoQR:Infections::Coinfection [DISEASES]Middle AgedMedical microbiologyHepatitis CTreatment OutcomeInfectious DiseasesTolerabilityResearch DesigncarbamatosVirusesFemaleHemodialysisPathogensVIH-1Research ArticleGlomerular Filtration RateMacrocyclic CompoundsClinical Research DesignLactams MacrocyclicResearch and Analysis MethodssulfonamidasRenal DialysisInternal medicineRibavirinMedical DialysismedicineDialysisTransplantationRenal Physiology/tratamiento farmacológicoRitonavirBiology and life sciencesbusiness.industryRibavirinestudios retrospectivosViral pathogensHepatitis C ChronicHepatitis virusesMicrobial pathogens:enfermedades parasitarias::coinfección [ENFERMEDADES]Spaindiálisis renalCo-InfectionsPhysical therapyinfecciones por VIHAdverse EventsbusinessHepatitis C - TractamenturaciloKidney diseasePLoS ONE
researchProduct

CCDC 968510: Experimental Crystal Structure Determination

2013

Related Article: Filippo Monti, Florian Kessler, Manuel Delgado, Julien Frey, Federico Bazzanini, Gianluca Accorsi, Nicola Armaroli, Henk J. Bolink, Enrique Ortí, Rosario Scopelliti, Md. Khaja Nazeeruddin, and Etienne Baranoff|2013|Inorg.Chem.|52|10292|doi:10.1021/ic400600d

(11'-methylenebis(3-methyl-imidazol-2-ylidene))-bis(2-phenylpyridine)-iridium hexafluorophosphate dichloromethane solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Deontología de las profesiones jurídicas

2010

Preguntas realizadas a la mesa redonda: Principios básicos de la deontología del abogado.Duración: 12M

5602 Ciències Jurídiques. Legislació
researchProduct

CCDC 968508: Experimental Crystal Structure Determination

2013

Related Article: Filippo Monti, Florian Kessler, Manuel Delgado, Julien Frey, Federico Bazzanini, Gianluca Accorsi, Nicola Armaroli, Henk J. Bolink, Enrique Ortí, Rosario Scopelliti, Md. Khaja Nazeeruddin, and Etienne Baranoff|2013|Inorg.Chem.|52|10292|doi:10.1021/ic400600d

(11'-methylenebis(3-methyl-imidazol-2-ylidene))-bis(2-(24-difluorophenyl)pyridine)-iridium hexafluorophosphate dichloromethane solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 968506: Experimental Crystal Structure Determination

2013

Related Article: Filippo Monti, Florian Kessler, Manuel Delgado, Julien Frey, Federico Bazzanini, Gianluca Accorsi, Nicola Armaroli, Henk J. Bolink, Enrique Ortí, Rosario Scopelliti, Md. Khaja Nazeeruddin, and Etienne Baranoff|2013|Inorg.Chem.|52|10292|doi:10.1021/ic400600d

Space GroupCrystallographybis(35-difluoro-2-(pyridin-2-yl)phenyl)-(1-hexyl-3-(4-methylpyridin-2-yl)-benzimidazol-2-ylidene)-iridium hexafluorophosphateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Principios deontológicos en las relaciones con los clientes

2010

Mesa redonda: Principios básicos de la deontología del abogado.Duración: 20M

5602 Ciències Jurídiques. Legislació
researchProduct

CCDC 968507: Experimental Crystal Structure Determination

2013

Related Article: Filippo Monti, Florian Kessler, Manuel Delgado, Julien Frey, Federico Bazzanini, Gianluca Accorsi, Nicola Armaroli, Henk J. Bolink, Enrique Ortí, Rosario Scopelliti, Md. Khaja Nazeeruddin, and Etienne Baranoff|2013|Inorg.Chem.|52|10292|doi:10.1021/ic400600d

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parametersbis(35-difluoro-2-(pyridin-2-yl)phenyl)-(1-methyl-3-(pyridin-2-yl)-imidazol-2-ylidene)-iridium hexafluorophosphate acetone solvateExperimental 3D Coordinates
researchProduct

CCDC 968505: Experimental Crystal Structure Determination

2013

Related Article: Filippo Monti, Florian Kessler, Manuel Delgado, Julien Frey, Federico Bazzanini, Gianluca Accorsi, Nicola Armaroli, Henk J. Bolink, Enrique Ortí, Rosario Scopelliti, Md. Khaja Nazeeruddin, and Etienne Baranoff|2013|Inorg.Chem.|52|10292|doi:10.1021/ic400600d

Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates(1-hexyl-3-(4-methylpyridin-2-yl)-benzimidazol-2-ylidene)-bis(2-(pyridin-2-yl)phenyl)-iridium hexafluorophosphate dichloromethane solvate
researchProduct

CCDC 968509: Experimental Crystal Structure Determination

2013

Related Article: Filippo Monti, Florian Kessler, Manuel Delgado, Julien Frey, Federico Bazzanini, Gianluca Accorsi, Nicola Armaroli, Henk J. Bolink, Enrique Ortí, Rosario Scopelliti, Md. Khaja Nazeeruddin, and Etienne Baranoff|2013|Inorg.Chem.|52|10292|doi:10.1021/ic400600d

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parametersbis(35-difluoro-2-(pyridin-2-yl)phenyl)-(1-methyl-3-(4-methylpyridin-2-yl)-imidazol-2-ylidene)-iridium hexafluorophosphate dichloromethane unknown solvateExperimental 3D Coordinates
researchProduct